The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxembourg, Sweden, Switzerland, and the United Kingdom
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
The submission is based on data from the STEP UP and STEP UP T2D clinical trials
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
Commercial production is expected to begin soon
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Subscribe To Our Newsletter & Stay Updated
